2-imino-4-(thio) oxo-5-polycyclovinylazolines for use as PI3 kinase inhibitors
US8106214B2 · kind B2 · utility
0Cited by
2References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 27, 2004 |
| Grant date | Jan 31, 2012 |
| Priority date | — |
| Expiry date | Jun 28, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is related to 2-imino-azolinone-vinyl fused-benzene derivatives of Formula (1) in particular for the treatment and/or prophylaxis of autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, kidney diseases, platelet aggregation, cancer, transplantation, graft rejection or lung injuries.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.